The US FDA has recently proposed a new draft framework that enables pharma manufacturers to add software to a drug label if they can demonstrate that the software adds clinical benefit to the drug.

If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. If you’ve ever wondered why some people seem to keep ...